Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.42 |
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL200824 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL8430564 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL198605 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL6658137 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL2584365 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL22129787 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL22407241 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL22407234 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL22129682 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 | |
| SCHEMBL22129681 | 1.00 | TSHR (0.50) | TSHRTHRBLMNADNM1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104017953-A | Overspeed quenching oil composition with excellent cooling rate stability | JIANGSU XINLU NEW MATERIALS CO LTD | 2014-09-03 | — | — | CN | claimed |
| CN-112204801-B | Battery device | 日产自动车株式会社 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024147345-A1 | COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES | ＡＰＢ株式会社 | 2024-07-11 | — | — | WO | disclosed |
| EP-3696891-B1 | METHOD FOR PRODUCING ELECTRODE FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | NISSAN MOTOR (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-11935998-B2 | Battery device | NISSAN MOTOR CO., LTD. (JP) | 2024-03-19 | — | — | US | disclosed |
| EP-3696887-B1 | ELECTRODE FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | NISSAN MOTOR (JP) | 2023-12-27 | — | — | EP | disclosed |
| US-20230387392-A1 | ELECTRODE FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | NISSAN MOTOR CO., LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| EP-4143280-B1 | PROCESS FOR THE PREPARATION OF POLYALKYL (METH)ACRYLATE POLYMERS | EVONIK OPERATIONS GMBH (DE) | 2023-11-29 | — | — | EP | disclosed |
| CN-111213263-B | Method for manufacturing electrode for nonaqueous electrolyte secondary battery | 日产自动车株式会社 | 2023-11-03 | — | — | CN | disclosed |
| WO-2023204215-A1 | ELECTRODE COMPOSITION FOR LITHIUM ION BATTERIES, COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, AND LITHIUM ION BATTERY | ＡＰＢ株式会社 | 2023-10-26 | — | — | WO | disclosed |
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-25 | — | — | US | disclosed |
| CN-101467276-A | Liquid crystalline rylene tetracarboxylic acid derivatives and use thereof | MAX PLANCK GESELLSCHAFT (DE) | 2009-06-24 | — | — | CN | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| EP-2008319-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007116001-A2 | LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-10-18 | — | — | WO | disclosed |
| EP-1843407-A1 | Liquid crystalline rylenetetracarboxylic acid derivatives and their use | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-10 | — | — | EP | disclosed |
| US-6746993-B2 | POLYMER CONTAINING C1-40ALKYL GROUP-CONTAINING (METH) ACRYLATES, (B) ALKYL ALKENYL ETHERS, (C) ALKENYL CARBOXYLATES, AND A NITROGEN CONTAINING UNSATURATED MONOMERS | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2004-06-08 | — | — | US | disclosed |
| US-20030104955-A1 | Viscosity index improver and lube oil containing the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-06-05 | — | — | US | disclosed |
| US-20030036488-A1 | Viscosity index improver and lube oil containing the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048904-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | TDO2, C9, CYP3A43 | TSHR 1062/4885THRB 1203/4885LMNA 1646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.